Correction to: Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Crossref DOI link: https://doi.org/10.1007/s40267-022-00901-1
Published Online: 2022-02-17
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Heo, Young-A
Text and Data Mining valid from 2022-02-01
Version of Record valid from 2022-02-17
Article History
First Online: 17 February 2022